Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver

Experimental and Therapeutic Medicine

Volumn 13, Issue 3, 2017, Pages 821-828

  Zaulet, Mihaela ^a   Kevorkian, Steliana Elvira Maria ^b   Dinescu, Sorina ^a   Cotoraci, Coralia ^c   Suciu, Maria ^b   Herman, Hildegard ^b   Buburuzan, Laura ^d   Badulescu, Liliana ^e   Ardelean, Aurel ^d   Hermenean, Anca ^b,d  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b Institute Of Life Sciences   (Romania)

^c Universitatea de Vest   (Romania)

^d VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

^e UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

Author keywords

Bisphenol A; Hepatoprotection; Hepatotoxicity; Pro inflammatory cytokines; Silymarin

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GLYCOGEN; INTERLEUKIN 6; MESSENGER RNA; SILYMARIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE CANALICULUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; GENE OVEREXPRESSION; GLYCOGEN SYNTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER INJURY; LIVER PROTECTION; LIVER STRUCTURE; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 85011621057     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4066     Document Type: Article

References (55)

1. Abdel-Wahab WM: Thymoquinone attenuates toxicity and oxidative stress induced by bisphenol A in liver of male rats. Pak J Biol Sci 17: 1152-1160, 2014.
2. Pritchett JJ, Kuester RK and Spies IG: Metabolism of bisphenol A in primary cultured hepatocytes from mice, rats, and humans. Drug Metab Dispos 30: 1180-1185, 2002.
3. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y and Taketani Y: Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 51: 165-169, 2004.
4. Mendiola J, Jørgensen N, Andersson AM, Calafat AM, Ye X, Redmon JB, Drobnis EZ, Wang C, Sparks A, Thurston SW, et al: Are environmental levels of bisphenol a associated with reproductive function in fertile men? Environ Health Perspect 118: 1286-1291, 2010.
5. Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C and Maggiolini M: Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect 120: 1177-1182, 2012.
6. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB and Melzer D: Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300: 1303-1310, 2008.
7. Duan B, Hu X, Zhao H, Qin J and Luo J: The relationship between urinary bisphenol A levels and meningioma in Chinese adults. Int J Clin Oncol 18: 492-497, 2013.
8. Rubin BS: Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27-34, 2011.
9. Vom Saal FS, Nagel SC, Coe BL, Angle BM and Taylor JA: The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 354: 74-84, 2012.
10. Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G and Reyes-Romero MA: Obesity and inflammation: Epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013: 678159, 2013.
11. Savastano S, Tarantino G, D'Esposito V, Passaretti F, Cabaro S, Liotti A, Liguoro D, Perruolo G, Ariemma F, Finelli C, et al: Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: A cross-sectional study on adult male population. J Transl Med 13: 169, 2015.
12. Weinhouse C, Anderson OS, Bergin IL, Vandenbergh DJ, Gyekis JP, Dingman MA, Yang J and Dolinoy DC: Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A. Environ Health Perspect 122: 485-491, 2014.
13. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT and Belcher SM: In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178-198, 2007.
14. Asahi J, Kamo H, Baba R, Doi Y, Yamashita A, Murakami D, Hanada A and Hirano T: Bisphenol A induces endoplasmic reticulum stress-associated apoptosis in mouse non-parenchymal hepatocytes. Life Sci 87: 431-438, 2010.
15. Bindhumol V, Chitra KC and Mathur PP: Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188: 117-124, 2003.
16. Moon MK, Kim MJ, Jung IK, Koo YD, Ann HY, Lee KJ, Kim SH, Yoon YC, Cho BJ and Park KS: Bisphenol a impairs mitochondrial function in the liver at doses below the no observed adverse effect level. J Korean Med Sci 27: 644-652, 2012.
17. Kang JS, Jeon YJ, Park SK, Yang KH and Kim HM: Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol 67: 175-181, 2004.
18. Najafzadeh H, Jalali MR, Morovvati H and Taravati F: Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload induced hepatotoxicity in rat. J Med Toxicol 6: 22-26, 2010.
19. Chtourou Y, Garoui E, Boudawara T and Zeghal N: Therapeutic efficacy of silymarin from milk thistle in reducing manganese-induced hepatic damage and apoptosis in rats. Hum Exp Toxicol 32: 70-81, 2013.
20. Panda V, Ashar H and Srinath S: Antioxidant and hepatoprotective effect of Garcinia indica fruit rind in ethanol-induced hepatic damage in rodents. Interdiscip Toxicol 5: 207-213, 2012.
21. Jia R, Cao L, Du J, Xu P, Jeney G and Yin G: The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio). In Vitro Cell Dev Biol Anim 49: 155-161, 2013.
22. Hermenean A, Stan M, Ardelean A et al: Antiioxidant and hepatoprotective activity of milk thistle (Silybum marianum L. Gaertn.) seed oil. Open Life Sci 10: 225-236, 2015.
23. Das S, Roy P, Auddy RG and Mukherjee A: Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomedicine 6 1291-1301, 2011.
24. Mansour HH, Hafez HF and Fahmy NM: Silymarin modulates Cisplatin induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 39: 656-661, 2006.
25. Sasu A, Herman H, Mariasiu T, Rosu M, Balta C, Anghel N, Miutescu E, Cotoraci C and Hermenean A: Protective effects of silymarin on epirubicin-induced mucosal barrier injury of the gastrointestinal tract. Drug Chem Toxicol 38: 442-451, 2015.
26. Rašković A, Stilinović N, Kolarović J, Vasović V, Vukmirović S and Mikov M: The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16: 8601-8613, 2011.
27. Vargas-Mendoza N, Madrigal-Santillán E, Morales-González A, Esquivel-Soto J, Esquivel-Chirino C, García-Luna Y González-Rubio M, Gayosso-de-Lucio JA and Morales-González JA: Hepatoprotective effect of silymarin. World J Hepatol 6: 144-149, 2014.
28. Karimi G, Vahabzadeh M, Lari P, Rashedinia M and Moshiri M: ‘Silymarin’, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci 14: 308-317, 2011.
29. Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY, Shyu JC, Hsieh YS, Tsai CC and Liu YC: Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J Viral Hepat 15: 508-514, 2008.
30. Ahmad I, Shukla S, Kumar A, Singh BK, Kumar V, Chauhan AK, Singh D, Pandey HP and Singh C: Biochemical and molecular mechanisms of N-acetyl cysteine and silymarin-mediated protection against maneb- and paraquat-induced hepatotoxicity in rats. Chem Biol Interact 201: 9-18, 2013.
31. Wu HJ, Liu C, Duan WX, Xu SC, He MD, Chen CH, Wang Y, Zhou Z, Yu ZP, Zhang L and Chen Y: Melatonin ameliorates bisphenol A-induced DNA damage in the germ cells of adult male rats. Mutat Re 752: 57-67, 2013.
32. Roelofs MJ, van den Berg M, Bovee TF, Piersma AH and van Duursen MB: Structural bisphenol analogues differentially target steroidogenesis in murine MA-10 Leydig cells as well as the glucocorticoid receptor. Toxicology 329: 10-20, 2015.
33. Rezg R, El-Fazaa S, Gharbi N and Mornagui B: Bisphenol A and human chronic diseases: Current evidences, possible mechanisms, and future perspectives. Environ Int 64: 83-90, 2014.
34. Markiewski MM, DeAngelis RA and Lambris JD: Liver inflammation and regeneration: Two distinct biological phenomena or parallel pathophysiologic processes? Mol Immunol 43: 45-56, 2006.
35. Thoolen B, Maronpot RR, Harada T, Nyska A, Rousseaux C, Nolte T, Malarkey DE, Kaufmann W, Küttler K, Deschl U, et al: Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38: (7 Suppl) 5S-81S, 2010.
36. Atsafack SS, Kuiate JR, Mouokeu RS, Koanga Mogtomo ML, Tchinda AT, De Dieu TJ, Magnifouet Nana H, Ebelle Etame RM, Biyiti L and Ngono Ngane RA: Toxicological studies of stem bark extract from Schefflera barteri Harms (Araliaceae). BMC Complement Altern Med 15: 44, 2015.
37. Weiss MJ: Cytokines in liver, biliary and pancreatic disease. In: Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Jarnagin W (ed). 5th edition. Elsevier, Inc., Philadelphia, PA, pp166-180, 2012.
38. Choi I, Kang HS, Yang Y and Pyun KH: IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol 95: 530-535, 1994.
39. Norris CA, He M, Kang LI, Ding MQ, Radder JE, Haynes MM, Yang Y, Paranjpe S, Bowen WC, Orr A, et al: Synthesis of IL-6 by hepatocytes is a normal response to common hepatic Stimuli. PLoS One 9: e96053, 2014.
40. Sherif IO and Al-Gayyar MMH: Antioxidant, anti-inflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite. Eur Cytokine Netw 24: 114-121, 2013.
41. Lovelace ES, Wagoner J, MacDonald J, Bammler T, Bruckner J, Brownell J, Beyer RP, Zink EM, Kim YM, Kyle JE, et al: Silymarin suppresses cellular inflammation by inducing reparative stress signaling. J Nat Prod 78: 1990-2000, 2015.
42. Pękalski J, Zuk PJ, Kochańczyk M, Junkin M, Kellogg R, Tay S and Lipniacki T: Spontaneous NF-kB activation by autocrine TNFa Signaling: A computational analysis. PLoS One 8: e78887, 2013.
43. Kabuto H, Amakawa M and Shishibori T: Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis inmice. Life Sci 74: 2931-2940, 2004.
44. Korkmaz A, Ahbab MA, Kolankaya D and Barlas N: Influence of vitamin C on bisphenol A, nonylphenol and octylphenol induced oxidative damages in liver of male rats. Food Chem Toxicol 48: 2865-2871, 2010.
45. Suthar H, Verma RJ, Patel S and Jasrai YT: Green tea potentially ameliorates bisphenol a-induced oxidative stress: An in vitro and in silico study. Biochem Res Int 2014: 259763, 2014.
46. Doerge DR and Fisher JW: Background paper on metabolism and toxicokinetics of bisphenol A. In: Proceedings of the WHO/HSE/FOS/11.1 Expert Meeting on Bisphenol A (BPA '10). World Health Organization, Geneva, 2010.
47. Xia W, Jiang Y, Li Y, Wan Y, Liu J, Ma Y, Mao Z, Chang H, Li G, Xu B, et al: Early-life exposure to bisphenol a induces liver injury in rats Involvement of mitochondria-mediated apoptosis PLoS One 9: e90443, 2014.
48. Muriel P, Garciapiña T, Perez-Alvarez V and Mourelle M: Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol 12: 439-442, 1992.
49. Jayashree S, Indumathi D, Akilavalli N, Sathish S, Selvaraj J and Balasubramanian K: Effect of Bisphenol-A on insulin signal transduction and glucose oxidation in liver of adult male albino rat. Environ Toxicol Pharmacol 35: 300-310, 2013.
50. Abouzeinab NS: Cytoprotective effect and antioxidant properties of silymarin on cisplatin induced hepatotoxicity in rats: A biochemical and histochemical study. International Journal of Cancer Research 9: 9-23, 2013.
51. Nelson DL and Cox MM (eds): Lehninger Principles of Biochemistry. 5th edition, W.H. Freeman and Co., New York, NY, pp540-550, 2008.
52. Ebaid H, Dkhil MA, Danfour MA, Tohamy A and Gabry MS: Piroxicam-induced hepatic and renal histopathological changes in mice. Libyan J Med 2: 82-89, 2007.
53. Miyamato Y, Shimada K, Sakaguchi Y and Miyamoto M: Cisplatin (CCDP)-induced acute toxicity in an experimental model of hepatic fibrosis. J Toxicol Sci 32: 311-319, 2007.
54. Rosner MH and Okusa M (eds): Biomarkers in Renal Disease. 5th edition. Nova Publishers, New York, NY, pp21-45, 2008.
55. Abdel Salam OM, Sleem AA, Omara EA and Hassan NS: Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats. Drug Target Insights 2: 19-27, 2007.